June 5, 2017
Cellphire Closes $3,000,000 Funding Round
Cellphire, Inc. announced today that it had closed a $3,000,000.00 funding round, with investments from both new investors and exisiting investors, management, and the board of directors.
April 3, 2017
Dr. Anne Hale, DVM Joins BodeVet as Chief Technical Officer
Cellphire, Inc. announced that Anne Hale, DVM has joined its veterinary subsidiary BodeVet, Inc. as its Chief Technical Officer. Dr. Hale is a renowned expert in veterinary transfusion medicine.
Dr. David Hirsh Joins Cellphire, Inc. Board of Directors
Cellphire, Inc. announced today that David I. Hirsh, Ph.D. has joined the Company’s Board of Directors. Dr. Hirsh is a Professor in the Department of Biochemistry and Molecular Biophysics at the College of Physicians and Surgeons of Columbia University.
March 6, 2017
BodeVet StablePlate RX® Launching in September at IVECCS 2017
BodeVet will release StablePlate RX, the world's first infusible freeze-dried platelet-derived product for canines, on a limited basis at the International Veterinary and Critical Care Symposium (IVECCS) in Nashville, Tennessee.
January 9, 2017
Rafael Jorda Joins Cellphire, Inc. as Vice President of R&D
Cellphire, Inc. announced today that Rafael Jorda has joined the company as Vice President of Research & Development. Mr. Jorda is an internationally experienced scientific leader with more than 25 years of experience in private and public company management spanning three continents.
November 14, 2016
In Memory of Dr. Arthur Bode
The Board, Officers and colleagues at Cellphire, Inc., commemorate their colleague Dr. Arthur P. Bode (b. 1953, d. 2016).
November 1, 2016
Rodman W. Moorhead, III Joins Cellphire, Inc. Board of Directors
Cellphire, Inc. announced today the appointment of Mr. Rodman W. Moorehead, III to its Board of Directors. Mr. Moorhead retired from Warburg Pincus, a global private equity firm, after a career spanning 37 years.
September 5, 2016
Cellphire Investors Receive 50% Maryland Biotechnology Investment Incentive Tax Credit
Cellphire, Inc. announced today that all investors who participated in the $1.3M Cellphire funding round that closed in August have received their Final Tax Credit Certificates from the Maryland Department of Commerce awarding them a 50 percent refundable tax credit for their investments in Cellphire.
